Checkpoint inhibitor-associated autoimmunity
Author:
Publisher
Elsevier BV
Subject
Rheumatology
Reference143 articles.
1. Pooled analysis of long-term survival data from phase II and phase III trials of ipilimumab in unresectable or metastatic melanoma;Schadendorf;J Clin Oncol,2015
2. Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma;Hamid;N Engl J Med,2013
3. Nivolumab in previously untreated melanoma without BRAF mutation;Robert;N Engl J Med,2015
4. Pembrolizumab for the treatment of non-small-cell lung cancer;Garon;N Engl J Med,2015
5. Nivolumab versus docetaxel in advanced squamous-cell non-small-cell lung cancer;Brahmer;N Engl J Med,2015
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Immune Checkpoint Inhibitor-induced Inflammatory Arthritis;Rheumatic Disease Clinics of North America;2024-05
2. Immunotoxicity Studies;Reference Module in Biomedical Sciences;2024
3. Shared Pathogenicity Features and Sequences between EBV, SARS-CoV-2, and HLA Class I Molecule-binding Motifs with a Potential Role in Autoimmunity;Clinical Reviews in Allergy & Immunology;2023-07-28
4. A novel pathologic marker, indoleamine 2,3-dioxygenase 1, for the cholangiopathy of immune checkpoint inhibitors-induced immune mediated hepatotoxicity as adverse events and the prediction of additional ursodeoxycholic acid treatment;Medical Molecular Morphology;2023-01-04
5. Myositis, myasthenia gravis, polyneuropathy and myocarditis: A life-threatening tetrad due to pembrolizumab;The Royal College of Radiologists Open;2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3